- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06097000
A Study of the Safety and Efficacy of Intelligent Powered Exoskeletons in Postoperative Spinal Rehabilitation
October 18, 2023 updated by: Xuanwu Hospital, Beijing
Systematic and professional rehabilitation training is generally effective for patients with lower limb dyskinesia, but most of them lose the chance of recovery due to failure to receive systematic rehabilitation treatment.
Our team has developed an intelligent power armor for patients with lower limb motor dysfunction, which can assist patients to complete high-quality rehabilitation training.
In order to evaluate the safety and efficacy of the Smart Power Armor for post-surgical spine patients, and to provide data support for a confirmatory clinical study, we designed a single-center, prospective, randomized controlled study to compare the level of recovery of lower limb motor function in patients with different rehabilitation strategies.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Wanru Duan
- Phone Number: 13581803400
- Email: duanwanru@xwhosp.org
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18-70 years old;
- Spinal surgery within 1 year due to degeneration, tumor, trauma or other reasons, postoperative motor disorders of both lower limbs, such as muscle weakness (3-5 level reduction), increased muscle tone, gait incoordination caused by deep sensory loss, etc.;
- The patient does not have a plan to rehabilitate in a specialized rehabilitation hospital, and plans to rehabilitate at home;
Exclusion Criteria:
- Short expected survival from malignant diseases;
- Muscle strength is less than grade 3, and the muscles of both lower limbs are severely atrophied;
- Suffering from other neurological diseases;
- Planned to undergo other surgeries within 3 months;
- Unable to cooperate with the transmission power external armor or cooperate with the rehabilitation training due to the physical condition;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Powered Exoskeleton Group
Rehabilitation exercises with powered exoskeletons
|
Whether to use powered exoskeletons for exercise rehabilitation
|
No Intervention: Traditional Group
Rehabilitation exercises without the use of powered exoskeletons
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Six-minute walk test
Time Frame: 3 months
|
meter; distance participants walked as fast as possible in a flat corridor in six minutes
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average rate of change in muscle strength
Time Frame: 3 months
|
(change in muscle strength level* number of persons)/total number of persons enrolled in the group
|
3 months
|
10 meter autonomous walking test
Time Frame: 3 months
|
meter; participants walk ten meters at a self-selected speed
|
3 months
|
10 meter fast walking test
Time Frame: 3 months
|
meter; participants walk ten meters at fastest speed
|
3 months
|
rate of change in hip joint mobility
Time Frame: 3 months
|
(hip joint mobility with assistance - hip joint mobility without assistance)/hip joint mobility without assistance; use joint mobility scales to measure hip joint mobility
|
3 months
|
stride length
Time Frame: 3 months
|
centimeter; left and right legs are measured separately
|
3 months
|
rate of change in heart rate
Time Frame: 3 months
|
(post-training heart rate - resting heart rate)/resting heart rate
|
3 months
|
rate of change in arterial partial pressure of oxygen
Time Frame: 3 months
|
(post-training arterial partial pressure of oxygen - arterial partial pressure of oxygen at rest)/arterial partial pressure of oxygen at rest
|
3 months
|
adverse event incidence rate
Time Frame: 12 months
|
Number of cases of adverse events/number of enrollees
|
12 months
|
serious adverse event incidence rate
Time Frame: 12 months
|
Number of cases of serious adverse events/number of enrollees
|
12 months
|
Thigh Swing Speed
Time Frame: 3 months
|
degrees/second; left and right legs are measured separately
|
3 months
|
Thigh Lifting Moment
Time Frame: 3 months
|
Newton*Meter; left and right legs are measured separately
|
3 months
|
Thigh Swing Angle
Time Frame: 3 months
|
degree; left and right legs are measured separately
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
October 20, 2023
Primary Completion (Estimated)
September 20, 2024
Study Completion (Estimated)
November 20, 2025
Study Registration Dates
First Submitted
September 27, 2023
First Submitted That Met QC Criteria
October 18, 2023
First Posted (Actual)
October 24, 2023
Study Record Updates
Last Update Posted (Actual)
October 24, 2023
Last Update Submitted That Met QC Criteria
October 18, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- XW-NS-IPEPSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exoskeleton Device
-
Vrije Universiteit BrusselActive, not recruitingExoskeleton DeviceBelgium
-
Ankara Yildirim Beyazıt UniversityRecruitingStroke | Exoskeleton Device | LocomotionTurkey
-
University Hospital TuebingenBASF; AUDI AG; BMW AG; Dachser Intelligent Logistics; Daimler AG; Deutsche Post AG; Iturri... and other collaboratorsCompletedPassive Upper-limb ExoskeletonGermany
-
Milton S. Hershey Medical CenterNot yet recruitingSafety Issues | Device Dislodgement | Device Intolerance | Device Ineffective
-
Schulthess KlinikCompletedDevice Success Rate | Device PerformanceSwitzerland, Austria
-
Biotronik, Inc.CompletedPostoperative Complications | Device Replacement | Device Upgrade | Elective Replacement (ERI) | Device AdvisoryUnited States
-
Assiut UniversityCompleted
-
Cairo UniversityCompletedIntrauterine DeviceEgypt
-
University Hospital, Basel, SwitzerlandClinical Trial Unit, University Hospital Basel, SwitzerlandCompletedMedical DeviceSwitzerland
-
Assiut UniversityRecruiting
Clinical Trials on powered exoskeletons
-
Alyn Pediatric & Adolescent Rehabilitation HospitalCompleted
-
Bioness IncCompletedShoulder Pain ChronicUnited States
-
North Carolina State UniversityRecruiting
-
University of MichiganRecruitingAmputationUnited States
-
Blekinge Institute of TechnologyKristianstad UniversityCompletedQuality of Life | Oral HealthSweden
-
VA New York Harbor Healthcare SystemWalter Reed National Military Medical CenterRecruitingProsthesis User | Lower Extremity ProblemUnited States
-
VA Office of Research and DevelopmentRecruiting
-
Blekinge Institute of TechnologyKristianstad UniversityCompletedPeriodontal Diseases | GingivitisSweden
-
James J. Peters Veterans Affairs Medical CenterCompletedParaplegiaUnited States
-
University of AlbertaGlobal Health Uganda LTDCompleted